MPT

Medical Properties Trust, Inc.
CAPPED RATING

Medical Properties Trust, Inc. (MPT) is rated C- (1.9/5) on Deltasharpe Prism, scored against Real Estate sector peers. Its strongest pillar is Value (B+); its weakest is Revisions (F).

Quantitative Factor Evaluation • Updated

Overall Rating
1.9 / 5.0
C-
Value
B+
Factor Score 3.7 / 5.0
Growth
C-
Factor Score 1.9 / 5.0
Profitability
B-
Factor Score 3.1 / 5.0
Momentum
F
Factor Score 0.5 / 5.0
Revisions
F
Factor Score 0.1 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 4.1
EV / EBITDA 10.3
Rev Growth YoY -5.4%
Gross Margin 95.7%
Price Return 3M -58.1%
Price Return 12M -63.6%
Catalyst Signal 0.00
Market Cap $1.0B
TTM Revenue $1.1B
Price / Sales 0.9
ROE 5.4%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 B+ (3.7) C- (1.9) B- (3.1) F (0.5) F (0.1) C- (1.9)
2026-11-06 B+ (3.7) C- (2.1) C+ (2.8) F (0.6) F (0.1) D+ (1.8)
2026-10-30 B (3.2) C- (2.1) B- (3.1) D- (0.8) C (2.4) C (2.3)
2026-10-23 B (3.2) C- (2.0) B- (3.1) D- (0.8) C (2.4) C (2.3)
2026-10-16 B- (3.1) C- (2.0) B- (3.1) D- (0.8) C (2.3) C (2.3)
Page 1 of 4